SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for AMWL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
March 31, 2026 25.45M
December 31, 2025 31.06M
September 30, 2025 30.81M
June 30, 2025 33.67M
March 31, 2025 35.77M
December 31, 2024 50.16M
September 30, 2024 41.95M
June 30, 2024 46.85M
March 31, 2024 58.48M
December 31, 2023 46.19M
September 30, 2023 49.95M
June 30, 2023 57.87M
March 31, 2023 59.10M
December 31, 2022 64.30M
September 30, 2022 56.18M
Date Value
June 30, 2022 53.63M
March 31, 2022 53.87M
December 31, 2021 35.94M
September 30, 2021 50.75M
June 30, 2021 39.00M
March 31, 2021 35.09M
December 31, 2020 42.83M
September 30, 2020 56.87M
June 30, 2020 92.43M
March 31, 2020 29.22M
December 31, 2019 27.74M
September 30, 2019 25.96M
June 30, 2019 25.16M
March 31, 2019 23.01M

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Doximity, Inc. 62.03M
GoodRx Holdings, Inc. 107.87M
Hims & Hers Health, Inc. 331.67M
Health Catalyst, Inc. 24.54M
HealthStream, Inc. 20.96M